
ProPhase Labs PRPH
Quarterly report 2025-Q3
added 11-19-2025
ProPhase Labs Total Inventories 2011-2026 | PRPH
Annual Total Inventories ProPhase Labs
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.98 M | 4.6 M | 3.04 M | 1.46 M | 1.9 M | 1.53 M | 2.74 M | 4.33 M | 3.29 M | 2.52 M | 2.05 M | 2.69 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.6 M | 1.46 M | 2.84 M |
Quarterly Total Inventories ProPhase Labs
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 266 K | 830 K | 1.14 M | 1.14 M | 3.97 M | 3.87 M | - | 3.84 M | 5.05 M | 3.62 M | 4.31 M | 3.98 M | 4.91 M | 4.51 M | 4.68 M | 4.6 M | 8.51 M | 15.2 M | 16 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.53 M | 1.53 M | 1.53 M | 1.53 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 4.33 M | 4.33 M | 4.33 M | 4.33 M | 3.29 M | 3.29 M | 3.29 M | 3.29 M | 2.52 M | 2.52 M | 2.52 M | 2.52 M | 2.05 M | 2.05 M | 2.05 M | 2.05 M | 2.69 M | 2.69 M | 2.69 M | 2.69 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16 M | 266 K | 3.32 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Assertio Holdings
ASRT
|
24.1 M | $ 19.29 | 0.42 % | $ 124 M | ||
|
Bausch Health Companies
BHC
|
1.54 B | $ 5.42 | 1.21 % | $ 1.98 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.02 | 1.7 % | $ 110 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B | ||
|
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 3.23 | 1.74 % | $ 45.4 M | ||
|
Evolus
EOLS
|
27 M | $ 4.2 | 4.09 % | $ 271 M | ||
|
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | ||
|
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
13.5 M | $ 35.93 | 1.76 % | $ 1.32 B | ||
|
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | ||
|
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | ||
|
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | ||
|
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M | ||
|
Organogenesis Holdings
ORGO
|
26.2 M | $ 2.35 | 4.69 % | $ 309 M | ||
|
Pacira BioSciences
PCRX
|
125 M | $ 22.39 | -1.37 % | $ 1.04 B | ||
|
Rockwell Medical
RMTI
|
3.42 M | $ 0.95 | -0.71 % | $ 34.2 M | ||
|
SCYNEXIS
SCYX
|
899 K | $ 0.94 | 5.6 % | $ 46.9 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 2.28 | -3.79 % | $ 2.83 M | ||
|
Tilray
TLRY
|
201 M | $ 6.78 | 3.44 % | $ 4.19 B | ||
|
Veru
VERU
|
4.14 M | $ 2.41 | 5.24 % | $ 325 M | ||
|
Jupiter Wellness
JUPW
|
949 K | - | - | $ 33.6 M | ||
|
Viatris
VTRS
|
3.52 B | $ 13.4 | -0.28 % | $ 16.1 B | ||
|
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | ||
|
Emergent BioSolutions
EBS
|
329 M | $ 8.28 | 0.61 % | $ 424 M | ||
|
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | ||
|
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | ||
|
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | ||
|
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
2.52 M | $ 0.75 | 0.76 % | $ 3.23 M | ||
|
Zomedica Corp.
ZOM
|
5.54 M | - | -0.21 % | $ 98 M | ||
|
China Pharma Holdings
CPHI
|
1.62 M | $ 0.66 | 5.06 % | $ 2.83 M | ||
|
TherapeuticsMD
TXMD
|
7.99 M | $ 2.1 | 5.0 % | $ 24.3 M |